# US 2021/0198706 A1 · Methods For Making and Using Polynucleotide Sequences in the Synthesis of Alkaloid Compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0198706 A1
- Document ID: US20210198706A1
- Status: Published application
- Kind: A1
- Application number: 16/657,183
- Filed: 2019-10-18
- Published: 2021-07-01
- Earliest claimed: 2014-04-29
- Assignees: Epimeron Inc.
- Applicants: Epimeron Inc.
- Inventors: Peter James Facchini
- Web page: https://patentgrep.com/patent/US20210198706A1

## CPC

- C12P 17/12: containing a six-membered hetero ring
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 15/1082: {Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors}
- C12N 15/81: for yeasts
- C12Y 201/01: Methyltransferases (2.1.1)
- C12N 15/1096: {cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR}
- C12N 15/63: Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C40B 10/00: Directed molecular evolution of macromolecules, e.g. RNA, DNA or proteins
- C40B 20/00: Methods specially adapted for identifying library members
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

Novel methods that may be used for the manufacture of plant alkaloid compounds and novel polynucleotide compounds are provided. The plant alkaloid compounds are useful as medicinal compounds.

## Claims

### Claim 1

A method of making an alkaloid compound, comprising:
(a) providing a first alkaloid compound;
(b) contacting the alkaloid compound with an O-methyltransferase under reaction conditions that permit methylation of the alkaloid compound to form a second alkaloid compound;
wherein the first alkaloid compound has the chemical formula:
wherein R1, R2, R3 and R4 each independently or simultaneously represent a hydroxyl group or a methoxy group, with the proviso that R2, R3 and R4 do not each simultaneously represent a methoxy group, and wherein represents a hydrogen atom or a methyl group;
and wherein the second alkaloid compound has the chemical formula:
and wherein R1, R2, R3 and R4 each independently or simultaneously represent a hydroxyl group or a methoxy group, with the proviso that at least one of R1, R2 R3 and R4 represents a methoxy group, and wherein R5 represents a hydrogen atom or a methyl group.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the O-Methyltransferase comprises SEQ.ID NO: 1592 or SEQ.ID NO: 1593, or a sequence that is at least 80% identical thereto.

### Claim 3 (depends on 1)

The method according to claim 1, wherein in the first alkaloid compound R1, R2, R3, and R4 represent a hydroxyl group, and R5 represents a hydrogen atom, and wherein in the second alkaloid compound R1 represents a methoxy group, R2, R3 and R4 represent a hydroxyl group and R5 represents a hydrogen atom.

### Claim 4 (depends on 2)

The method according to claim 2, wherein in the first alkaloid compound R1, R2, R3, and R4 represent a hydroxyl group, and R5 represents a hydrogen atom, and wherein in the second alkaloid compound R1 represents a methoxy group, R2, R3 and R4 represent a hydroxyl group and R5 represents a hydrogen atom.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the method is performed in in vitro.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the method is performed in vivo in a cell, wherein the cell has been transformed with a nucleic acid sequence encoding the O-methyl-transferase.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the nucleic acid sequence encoding the O-methyltransferase is a polypeptide comprising SEQ.ID NO: 1592 or SEQ.ID NO: 1593, or a sequence that is at least 80% identical thereto.

### Claim 8 (depends on 7)

The method according to claim 7, wherein in the first alkaloid compound R1, R2, R3, and R4 represent a hydroxyl group, and R5 represents a hydrogen atom, and wherein in the second alkaloid compound R1 represents a methoxy group, R2, R3 and R4 represent a hydroxyl group, and R5 represents a hydrogen atom.

### Claim 9 (depends on 6)

The method according to claim 6, wherein the cell is a microbial cell.

### Claim 10 (depends on 6)

The method according to claim 6, wherein the cell is a plant cell.

### Claim 11 (depends on 9)

The method according to claim 9, wherein the microbial cell is a bacterial cell or a yeast cell.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the bacterial cell is Escherichia coli cell.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the yeast cell is a Saccharomyces cerevisiae cell.

### Claim 14 (depends on 6)

A cell for the performance of the method according to claim 6, wherein the cell is transformed with SEQ.ID NO: 1592 or 1593 or a sequence that is at least 80% identical thereto.

### Claim 15 (depends on 8)

A cell for the performance of the method according to claim 8, wherein the cell is transformed with SEQ.ID NO: 1592 or 1593 or a sequence that is at least 80% identical thereto.

### Claim 16 (depends on 14)

The cell according to claim 14, wherein the cell is a microbial cell.

### Claim 17 (depends on 14)

The cell according to claim 14, wherein the cell is a plant cell.

### Claim 18 (depends on 16)

The cell according to claim 16, wherein the microbial cell is a bacterial cell or a yeast cell.

### Claim 19 (depends on 18)

The cell according toc claim 18, wherein the bacterial cell is an Escherichia coli cell.

### Claim 20 (depends on 18)

The cell according to claim 18, wherein the yeast cell is a Saccharomyces cerevisiae cell.
